Conexeu says CXU preclinical program completes 12-month P..O.F. phase, meets objectivesPUBT·Aug 18 at 07:55 AMCNXU+0.43%
Conexeu Sciences CMO presents on extracellular matrix role in tissue regeneration at Laser & Cosmetic Surgery symposiumPUBT·Aug 11 at 07:32 AMCNXU+0.43%
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Datarttnews·Jul 15 at 10:42 PMIOVA-3.03%MANE-3.81%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 15 at 12:05 PMCRDF-4.67%SNTI-0.13%
11:01 ETThe GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.prnewswire·Jul 15 at 10:02 AMCNXU+0.43%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 7 at 12:05 PMCRNX-0.01%AKTX+18.76%
A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill ItPR Newswire·Jul 7 at 08:45 AMCNXU+0.43%
Conexeu Sciences director Andrew Costa files initial beneficial ownership statementPUBT·Jun 29 at 05:15 AMCNXU+0.43%
